1. Home
  2. MTSR vs OSCR Comparison

MTSR vs OSCR Comparison

Compare MTSR & OSCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MTSR
  • OSCR
  • Stock Information
  • Founded
  • MTSR 2022
  • OSCR 2012
  • Country
  • MTSR United States
  • OSCR United States
  • Employees
  • MTSR N/A
  • OSCR N/A
  • Industry
  • MTSR
  • OSCR Accident &Health Insurance
  • Sector
  • MTSR
  • OSCR Finance
  • Exchange
  • MTSR NYSE
  • OSCR Nasdaq
  • Market Cap
  • MTSR 3.0B
  • OSCR 3.2B
  • IPO Year
  • MTSR 2025
  • OSCR 2021
  • Fundamental
  • Price
  • MTSR $40.47
  • OSCR $14.45
  • Analyst Decision
  • MTSR Strong Buy
  • OSCR Sell
  • Analyst Count
  • MTSR 6
  • OSCR 7
  • Target Price
  • MTSR $55.25
  • OSCR $12.79
  • AVG Volume (30 Days)
  • MTSR 803.5K
  • OSCR 41.0M
  • Earning Date
  • MTSR 08-26-2025
  • OSCR 08-06-2025
  • Dividend Yield
  • MTSR N/A
  • OSCR N/A
  • EPS Growth
  • MTSR N/A
  • OSCR N/A
  • EPS
  • MTSR N/A
  • OSCR 0.46
  • Revenue
  • MTSR N/A
  • OSCR $10,081,522,000.00
  • Revenue This Year
  • MTSR N/A
  • OSCR $25.81
  • Revenue Next Year
  • MTSR N/A
  • OSCR $0.60
  • P/E Ratio
  • MTSR N/A
  • OSCR $31.29
  • Revenue Growth
  • MTSR N/A
  • OSCR 54.26
  • 52 Week Low
  • MTSR $12.30
  • OSCR $11.20
  • 52 Week High
  • MTSR $47.40
  • OSCR $23.79
  • Technical
  • Relative Strength Index (RSI)
  • MTSR N/A
  • OSCR 44.38
  • Support Level
  • MTSR N/A
  • OSCR $12.86
  • Resistance Level
  • MTSR N/A
  • OSCR $15.92
  • Average True Range (ATR)
  • MTSR 0.00
  • OSCR 1.20
  • MACD
  • MTSR 0.00
  • OSCR -0.17
  • Stochastic Oscillator
  • MTSR 0.00
  • OSCR 34.50

About MTSR METSERA INC

Metsera Inc is a clinical-stage biotechnology company developing next-generation injectable and oral nutrient-stimulated hormone (NuSH) analog peptides to treat obesity, overweight, and related conditions. The Company has developed and is implementing proprietary methods and platform technologies to advance a broad, scalable, and combinable portfolio of injectable and oral NuSH analog peptides with the potential to address not only the limitations of approved therapies but also many of the anticipated limitations of next-generation therapies in development. The Company uses its proprietary MINT peptide library of NuSH analog peptides alongside its Half-life Augmentation by Lipid Optimization half-life extending platform.

About OSCR Oscar Health Inc.

Oscar Health Inc is a health insurance company. The company provides various insurance plans for individuals, families, and employees. Also, the company provides virtual care, doctor support, scheduling appointments, and other related services. The company provides plans in the Medicare Advantage program to adults who are age 65 and older and eligible for traditional Medicare but who instead select coverage through a private market plan.

Share on Social Networks: